OMNI announced the company has reached an agreement with a major Indian pharmaceutical company to develop an inhalation product in the US and European markets

The first subject was successfully enrolled in the phase III clinical trial of OMNI StarE study

Comprehensive training of OMNI StarE clinical study executive team was launched

The National Kick-off Meeting of the OMN-SF-301 (StarE) study was successfully held in Beijing